
Newly Funded Research Promoting Retinal Cell Axon Regeneration is Underway Thanks to NEI’s Audacious Goals Initiative
Optic nerve regeneration could be the answer to curing glaucoma, or at least substantially slowing the progression of the disease.
Optic nerve regeneration could be the answer to curing glaucoma, or at least substantially slowing the progression of the disease.
Stem cells are poised to make an impact on glaucoma research and treatment, as adult stem cells can be taken from the eye or skin, and used to try to replace damaged cells in your eye.
A research study has found that high-contrast visual activity promotes optic nerve regrowth.
New contact lens technologies could make it easier for patients to comply with their medication plans and monitor both the progress of the disease and the efficacy of newly prescribed drugs.
Nerve regeneration focuses on ways to regrow nerves. Neuroprotection is preventing the death of nerve cells. Both goals must be developed before vision loss due to glaucoma can be stopped or reversed.
What causes vision loss in glaucoma? First is elevated ocular pressure, and second is damage to the optic nerve, which is the structure that sends visual information to the brain.
Stanford researchers, funded in part by the National Eye Institute and the Glaucoma Research Foundation, make discovery that may help glaucoma patients who have lost vision.
Members of our Scientific Advisory Board talk about the success of the Catalyst for a Cure collaborative research model.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.